Viatris Inc (VTRS) - News Archive

The Law of the Land: Viatris Inc. Investors Urged to Stand Up for JusticeIn a striking turn of events, investors of Viatris Inc. (NASDAQ: VTRS) are being called to action as Bronstein, Gewirtz & Grossman LLC, a renowned...

This article reviews the recent developments concerning Viatris Inc. (NASDAQ: VTRS), which is currently facing a class action lawsuit filed by a prominent law firm, Bronstein, Gewirtz & Grossman LLC. This legal action h...

By July 4, 2025 - New York Rosen Law Firm, a prominent global investor rights law firm, is encouraging investors of Viatris Inc. (NASDAQ: VTRS) to secure legal representation before the looming lead plaintiff deadline i...

In the rapidly evolving landscape of pharmaceutical stocks, Viatris Inc. (NASDAQ: VTRS) has become a focal point for investors following the announcement of a class action securities lawsuit. Investors have until June 3...

Navigating Financial Straits: Viatris Inc. s Improving Receivables Amidst Sector Challenges In the fast-evolving landscape of pharmaceutical sciences, fiscal resilience stands as a paramount pillar for sustained success...

In the world of investments, timelines can make all the difference. As investors grapple with market fluctuations and corporate announcements, the importance of staying informed cannot be overstated. The Rosen Law Firm,...

In an unexpected turn of events, Viatris Inc. (NASDAQ: VTRS) finds itself embroiled in a legal battle that could have significant implications for the pharmaceutical giant s future. The class action lawsuit, announced b...

Viatris Inc. Faces Class Action Lawsuit Amid Deteriorating Receivables Performance Viatris Inc. (NASDAQ: VTRS) is currently under scrutiny following the filing of a class action lawsuit, which has attracted the attentio...

PITTSBURGH, April 15, 2024 - Viatris Inc. (NASDAQ: VTRS), a global healthcare company, announced today the appointment of Corinne Le Goff as Chief Commercial Officer. Le Goff will also join the esteemed Executive Leader...

PITTSBURGH, Dec. 15, 2023 - Viatris Inc. (NASDAQ: VTRS), a global healthcare company, publicly disclosed its preparations for Phase 2 of its strategic plan by appointing Theodora Doretta Mistras as Chief Financial Offic...